Skip to main content
. 2023 Mar 28;14:1150803. doi: 10.3389/fimmu.2023.1150803

Table 2.

The association between the percentages of CD226+ cells, CD226+ cells in the epithelial cell region, and CD226+ cells in the stromal cell region in tumor and clinical features of GC patients.

Clinical parameters cases CD226+ cells infiltration OR χ 2 P-value CD226+ cells infiltration OR χ 2 P-value CD226+ cells infiltration OR χ 2 P-value
Low High Low High Low High
Gender
 Male 64 37 27 1.542 1.034 0.309 48 16 1.435 0.601 0.438 46 18 1.065 0.018 0.893
 Female 34 16 18 23 11 24 10
Age (years)
 <66 50 23 27 0.499 2.803 0.094 32 18 0.432 3.201 0.074 30 20 0.316 5.928 0.015
 ≥66 46 29 17 37 9 38 8
Tumor size (cm)
 <5.5 48 23 25 0.603 1.510 0.219 34 14 0.810 0.211 0.646 31 17 0.480 2.525 0.112
 ≥5.5 48 29 19 36 12 38 10
T stage
 T1-2 15 7 8 0.719 0.344 0.558 10 5 0.733 0.267 0.605 11 4 1.138 0.011 0.916
 T3-4 82 45 37 60 22 58 24
N stage
 N0 27 15 12 1.053 0.013 0.910 18 9 0.642 0.813 0.367 20 7 1.143 0.068 0.794
 N1-3 70 38 32 53 17 50 20
M stage
 M0 89 46 43 0.153 2.491 0.115 64 25 0.366 0.288 0.591 62 27 0.328 0.435 0.510
 M1 8 7 1 7 1 7 1
Pathological stage
 II+III 87 48 39 1.477 0.371 0.542 62 25 0.551 0.144 0.704 62 25 0.930 0.064 0.800
 IV 11 5 6 9 2 8 3
TNM
 I+II 41 22 19 0.896 0.070 0.792 28 13 0.601 1.193 0.275 32 9 1.730 1.349 0.245
 III+IV 55 31 24 43 12 37 18

The values of cutoff point were 3.683 (in total region), 0.053 (in epithelial region), 0.070 (in stromal region). Values higher than the cutoff point were defined as “High”, and others were defined as “Low”. Bold signifies P<0.05.